8-[(2-cyclopropyl-6-fluorophenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-(2-thiophen-2-ylethynyl)pyrido[2,3-d]pyrimidin-7-one;8-[(2-ethylsulfonylphenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylsulfonylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one
C128H133FN26O10S3 — CID 160618175
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[(2-cyclopropyl-6-fluorophenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-(2-thiophen-2-ylethynyl)pyrido[2,3-d]pyrimidin-7-one;8-[(2-ethylsulfonylphenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylsulfonylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one
8-[(2-cyclopropyl-6-fluorophenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-(2-thiophen-2-ylethynyl)pyrido[2,3-d]pyrimidin-7-one;8-[(2-ethylsulfonylphenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylsulfonylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one (PubChem CID 160618175) has the molecular formula C128H133FN26O10S3 and a molecular weight of 2310.84 g/mol. Its IUPAC name is 8-[(2-cyclopropyl-6-fluorophenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-(2-thiophen-2-ylethynyl)pyrido[2,3-d]pyrimidin-7-one;8-[(2-ethylsulfonylphenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylsulfonylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one.
Molecular Properties
| Compound Name | 8-[(2-cyclopropyl-6-fluorophenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-(2-thiophen-2-ylethynyl)pyrido[2,3-d]pyrimidin-7-one;8-[(2-ethylsulfonylphenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylsulfonylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one |
|---|---|
| PubChem CID | 160618175 |
| Molecular Formula | C128H133FN26O10S3 |
| Molecular Weight | 2310.84 g/mol |
| Exact Mass | 2308.98 |
| IUPAC Name | 8-[(2-cyclopropyl-6-fluorophenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-(2-thiophen-2-ylethynyl)pyrido[2,3-d]pyrimidin-7-one;8-[(2-ethylsulfonylphenyl)methyl]-2-[4-(4-methylpiperazin-1-yl)anilino]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one;2-[4-(4-methylpiperazin-1-yl)anilino]-8-[(2-morpholin-4-ylsulfonylphenyl)methyl]-6-prop-1-ynylpyrido[2,3-d]pyrimidin-7-one |
| SMILES | CC#Cc1cc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n(Cc2ccccc2N2CCOCC2)c1=O.CC#Cc1cc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n(Cc2ccccc2S(=O)(=O)CC)c1=O.CC#Cc1cc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n(Cc2ccccc2S(=O)(=O)N2CCOCC2)c1=O.CN1CCN(c2ccc(Nc3ncc4cc(C#Cc5cccs5)c(=O)n(Cc5c(F)cccc5C5CC5)c4n3)cc2)CC1 |
| InChI | InChI=1S/C34H31FN6OS.C32H35N7O4S.C32H35N7O2.C30H32N6O3S/c1-39-15-17-40(18-16-39)27-12-10-26(11-13-27)37-34-36-21-25-20-24(9-14-28-4-3-19-43-28)33(42)41(32(25)38-34)22-30-29(23-7-8-23)5-2-6-31(30)35;1-3-6-24-21-26-22-33-32(34-27-9-11-28(12-10-27)37-15-13-36(2)14-16-37)35-30(26)39(31(24)40)23-25-7-4-5-8-29(25)44(41,42)38-17-19-43-20-18-38;1-3-6-24-21-26-22-33-32(34-27-9-11-28(12-10-27)37-15-13-36(2)14-16-37)35-30(26)39(31(24)40)23-25-7-4-5-8-29(25)38-17-19-41-20-18-38;1-4-8-22-19-24-20-31-30(32-25-11-13-26(14-12-25)35-17-15-34(3)16-18-35)33-28(24)36(29(22)37)21-23-9-6-7-10-27(23)40(38,39)5-2/h2-6,10-13,19-21,23H,7-8,15-18,22H2,1H3,(H,36,37,38);4-5,7-12,21-22H,13-20,23H2,1-2H3,(H,33,34,35);4-5,7-12,21-22H,13-20,23H2,1-2H3,(H,33,34,35);6-7,9-14,19-20H,5,15-18,21H2,1-3H3,(H,31,32,33) |
| InChIKey | RGJAUPSUAQGPKL-UHFFFAOYSA-N |
| XLogP | 15.58 |
| TPSA | 358.38 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 36 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 168 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2310.84 |
| LogP ≤ 5 | 15.58 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 36 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160618175 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.